May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
A Retrospective Study of Transpupillary Thermotherapy (TTT) for Choroidal Neovascularization in Age–Related Macular Degeneration (ARMD)
Author Affiliations & Notes
  • S.C. N. Oliver
    Ophthalmology, Rocky Mtn Lions Eye Institute, Univ of Colorado, Aurora, CO
  • S. Petty
    Ophthalmology, Porter Hospital, Denver, CO
  • Footnotes
    Commercial Relationships  S.C.N. Oliver, None; S. Petty, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1405. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.C. N. Oliver, S. Petty; A Retrospective Study of Transpupillary Thermotherapy (TTT) for Choroidal Neovascularization in Age–Related Macular Degeneration (ARMD) . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1405.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the effectiveness of transpupillary thermotherapy (TTT) for occult and classic choroidal neovascularization (CNV) in age–related macular degeneration (ARMD). Methods: Retrospective case series of 106 eyes from 101 patients with occult CNV with or without pigment epithelial detachment or with classic AMD with acuity ≤20/400. TTT was applied a maximum of four times and patients were followed for change in visual acuity, resolution of macular edema, and CNV recurrence. Results: Of 106 eyes treated, 87% presented with occult lesions, while 13% were classic. At initial 3 month follow–up, visual acuity was stable (+/– 1 line) in 68%, improved in 12%, and worse in 20%, while exudation diminished in 63%. At 10 month follow–up, visual acuity was stable in 56%, improved in 8%, and worse in 30%. PED was present in 13% of patients. At 6 month follow–up for the PED subgroup, vision was stable in 57%, better in 14%, and worse in 29%. The recurrence rate for CNV in the entire series was 10.4%, while it increased to 21% in the PED subgroup. No pigment epithelial tears occurred. Conclusions: TTT may cause or acclerate resolution of macular edema in CNV. TTT results in visual improvement (≥2 lines) in only 8% of cases, however 55% are stable (+/– 1 line), 64% lose 1 line or less (stable or get better), and 75% lose 2 lines or less. PED may be successfully treated with TTT, but CNV recurrence rates may be higher than in non–PED subgroups.

Keywords: macula/fovea • laser • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×